XML 89 R78.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Segment Reporting - Reconciliation of Segment Profits to Income before Taxes (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Segment Reporting Information [Line Items]        
Profits $ 6,006 $ (5,335) $ 11,675 $ (1,685)
Interest income 69 109 141 221
Interest expense (310) (277) (613) (519)
Amortization     (1,087) (1,020)
Depreciation     (1,029) (874)
Research and development (3,500) (13,321) (7,492) (17,597)
Restructuring costs (80) (151) (202) (218)
Operating Segments        
Segment Reporting Information [Line Items]        
Profits 11,708 10,321 23,168 20,025
Operating Segments | Pharmaceutical segment        
Segment Reporting Information [Line Items]        
Profits 11,200 9,854 22,104 18,993
Operating Segments | Animal Health segment        
Segment Reporting Information [Line Items]        
Profits 508 467 1,064 1,032
Corporate, Non-Segment        
Segment Reporting Information [Line Items]        
Profits 129 19 274 184
Interest income 69 109 141 221
Interest expense (310) (277) (613) (519)
Amortization (614) (477) (1,087) (1,020)
Depreciation (450) (376) (902) (775)
Research and development (3,360) (13,194) (7,209) (17,341)
Restructuring costs (80) (151) (202) (218)
Charge for Zetia antitrust litigation settlements 0 0 0 (573)
Other unallocated, net $ (1,086) $ (1,309) $ (1,895) $ (1,669)